Development of an UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study

BACKGROUND: Upadacitinib, a novel selective Janus kinase 1 (JAK1) inhibitor, has been recently approved by the US FDA for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA). An ultra-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) met...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Meng-Jie, Zhao, Yu-Hang, Fan, Chen, Wang, Ying-Jie, Wang, Xin-Qi, Qiu, Xiang-Jun, Shen, Rui-Le
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495142/
https://www.ncbi.nlm.nih.gov/pubmed/34629864
http://dx.doi.org/10.2147/DDDT.S332282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495142/
https://www.ncbi.nlm.nih.gov/pubmed/34629864
http://dx.doi.org/10.2147/DDDT.S332282

Ejemplares similares